Kohnen T, von Ehr M, Schütte E
Abteilung Augenheilkunde, Bundeswehrkrankenhaus Ulm.
Klin Monbl Augenheilkd. 1995 Jul;207(1):29-36. doi: 10.1055/s-2008-1035345.
Viscoelastic substances are used in anterior segment surgery to reduce tissue trauma and endothelial cell loss and to serve as space maintainer. Healon GV (approximately greater viscosity), a hyaluronic acid product with a ten times higher viscosity than Healon, is utilized in complicated procedures (vitreous pressure, flat anterior chamber, congenital cataracts, etc.) and often in phacoemulsification. Intraocular pressure (IOP) rise following incomplete removal is a known problem.
A prospective randomized study was performed to evaluate the IOP following cataract surgery with Healon or Healon GV and different removal times (RT). Forty patients (forty eyes) having uncomplicated phacoemulsification with foldable silicone posterior chamber lens implantation and identical viscoelastic removal technique were assigned to four groups: Healon with 20 or 40 seconds (sec.) RT, Healon GV with 20 or 40 sec. RT. All surgeries were performed by the same surgeon using the same technique especially for the removal of the viscoelastic. All patients had an identical pre- and postoperative medication. Intraocular pressures were obtained using Goldman's applanation tonometry preoperatively, six, 24, 36, and 48 hours postoperatively.
The IOP follow-up showed no significant difference between the two viscoelastic substances and the two different removal times of 20 and 40 sec. (t-test). In four patients (two of the Healon-groups, two of the Healon GV-groups) the IOP required treatment. On the second postoperative day, the same four patients showed IOP lower than 22 mm Hg. The highest mean-IOP (mm Hg) in both Healon-groups was obtained at 24 hours postoperatively: 18.5 +/- 3.9 SD (Healon); 17.3 +/- 5.9 SD (Healon GV).
The incidence of postoperative rise in IOP using high viscosity hyaluronic acid (Healon GV) can be minimized by the applied removal technique. Both viscoelastics-despite of higher molecular weight and viscosity-can be removed equally from the anterior chamber following phacoemulsification and posterior chamber lens implantation utilizing IOP as a parameter in vivo.
粘弹性物质用于眼前节手术,以减少组织创伤和内皮细胞损失,并作为空间维持剂。Healon GV(粘度约更高)是一种透明质酸产品,其粘度比Healon高十倍,用于复杂手术(玻璃体压力、无前房、先天性白内障等),且常用于超声乳化手术。已知不完全清除后会出现眼压(IOP)升高的问题。
进行了一项前瞻性随机研究,以评估白内障手术中使用Healon或Healon GV以及不同清除时间(RT)后的眼压。40例(40眼)接受了可折叠硅胶后房型人工晶状体植入且采用相同粘弹性清除技术的单纯超声乳化手术患者被分为四组:Healon组,清除时间为20秒或40秒;Healon GV组,清除时间为20秒或40秒。所有手术均由同一位外科医生使用相同技术进行,尤其是粘弹性物质的清除。所有患者术前和术后用药相同。术前、术后6小时、24小时、36小时和48小时使用戈德曼压平眼压计测量眼压。
眼压随访显示,两种粘弹性物质以及20秒和40秒这两种不同清除时间之间无显著差异(t检验)。4例患者(Healon组2例,Healon GV组2例)的眼压需要治疗。术后第二天,这4例患者的眼压均低于22 mmHg。Healon组术后24小时的平均眼压最高(mmHg):18.5±3.9标准差(Healon);17.3±5.9标准差(Healon GV)。
通过应用的清除技术,使用高粘度透明质酸(Healon GV)导致术后眼压升高的发生率可降至最低。在超声乳化和后房型人工晶状体植入术后,以眼压作为体内参数,尽管两种粘弹性物质分子量和粘度较高,但均可从前房中同等程度地清除。